Trial intelligence / Profile preview

Dexmedetomidine-Ketamine vs Dexmedetomidine-Propofol in Burr-Hole Surgery

NCT04621526Phase 2Completed

Sponsor
Zagazig University
Start
Nov 2020
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of dexmedetomidine, ketamine and propofol injection (veterinary) in chronic subdural hematoma (CSDH), sponsored by Zagazig University. Started Nov 2020; status: completed.

02

Drugs

dexmedetomidineketaminepropofol injection (veterinary)
03

Conditions

chronic subdural hematoma (CSDH)

Beyond the preview

Go deeper on NCT04621526.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04621526.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call